Replies to post #54224 on RespireRx Pharmaceuticals Inc (fka RSPI)

[LTListener]

They haven’t done anything with OSA program since 2023 and the VP looking for financing left. my speculation is it could be related to clarity on cannibas rescheduling in USA.. they mentioned some related commercial proposal in shareholder letter as well. So who knows.